Defining Device Success for Percutaneous Coronary Intervention Trials: A Position Statement from the European Association of Percutaneous Cardiovascular Interventions of the European Society of Cardiology.

Chang, Chun Chin; Kogame, Norihiro; Onuma, Yoshinobu; Byrne, Robert A; Capodanno, Davide; Windecker, Stephan; Morel, Marie-Angèle; Cutlip, Donald E; Krucoff, Mitchell W; Stone, Gregg W; Lansky, Alexandra J; Mehran, Roxana; Spitzer, Ernest; Fraser, Alan G; Baumbach, Andreas; Serruys, Patrick W (2020). Defining Device Success for Percutaneous Coronary Intervention Trials: A Position Statement from the European Association of Percutaneous Cardiovascular Interventions of the European Society of Cardiology. EuroIntervention, 15(13), pp. 1190-1198. Europa Digital & Publishing 10.4244/EIJ-D-19-00552

[img] Text
55_31475907 Defining Device Success.pdf - Accepted Version
Restricted to registered users only
Available under License Publisher holds Copyright.

Download (3MB) | Request a copy
[img] Text
defining-device-success-for-percutaneous-coronary-intervention-trials-aposition-.pdf - Published Version
Restricted to registered users only
Available under License Publisher holds Copyright.

Download (1MB) | Request a copy

Percutaneous coronary intervention with implantation of drug-eluting stents has become the most commonly performed revascularization procedure in patients with symptomatic coronary artery disease. Continuous iterations of coronary devices incorporating changes in platform materials, geometry, strut thickness, drug-release mechanisms and anti-proliferative drugs, have progressively reduced the rate of device-related adverse clinical events, and objective performance criteria have been proposed for clinical and angiographic outcomes of drug-eluting stents. The rate of device success has been recognized as an intra-procedural endpoint to evaluate the mechanical ability to complete a procedure with the specific device assigned by protocol in randomized comparative trials. The European Commission and the U.S. Food and Drug Administration both provide guidance documents including the mechanistic evaluation of coronary stents which recommend operational definitions of device success. While the majority of clinical trials investigating drug-eluting stents have adopted this endpoint definition, inconsistencies in application limit the reliability of comparisons across different trials reporting device success rates. In addition, it is not uncommon that device success rates are not reported by investigators. A consistent definition of device success is essential to allow scientific comparisons of this technical performance endpoint between devices across different trials. Therefore, we performed a systematic evaluation of definitions and reporting of device success in clinical trials. We propose an extended definition as well as considerations for approaching the determination of the device success rates in future percutaneous coronary intervention trials.

Item Type:

Journal Article (Review Article)

Division/Institute:

04 Faculty of Medicine > Department of Cardiovascular Disorders (DHGE) > Clinic of Cardiology

UniBE Contributor:

Windecker, Stephan

Subjects:

600 Technology > 610 Medicine & health

ISSN:

1774-024X

Publisher:

Europa Digital & Publishing

Language:

English

Submitter:

Nadia Biscozzo

Date Deposited:

10 Feb 2020 11:23

Last Modified:

13 Feb 2020 05:23

Publisher DOI:

10.4244/EIJ-D-19-00552

PubMed ID:

31475907

BORIS DOI:

10.7892/boris.139087

URI:

https://boris.unibe.ch/id/eprint/139087

Actions (login required)

Edit item Edit item
Provide Feedback